Impact Factor for Five Years is 1.55 (2012 - 2016). IJPRT Re-launched from 2017, for more details visit www.ijprtonline.com

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
Article In Press
ENZYMATIC AND NON ENZYMATIC ANTIOXIDANT ACTIVITY OF LEAF EXTRACTS OF AEGLE MARMELOS L. AND CENTELLA ASIATICA L.
ECO-FRIENDLY SYNTHESIS OF SILVER NANOPARTICLES USING AQUEOUS LEAVES EXTRACT OF CLOME GYNANDRA AND THEIR ANTIBACTERIAL ACTIVITY”
Synthesis, characterization, augmentation of iron oxide nanoparticles from Musa paradisaca peel extract and its antibacterial activity
Antianaphylactic Activity Polyherbal Formulation Against Systemic, Cutaneous And Compound 48/80 Induced Invitro Anaphylaxis
A study on an autoimmune disease-PSORIASIS
EFFICACY OF EMBLICA OFFICINALIS ON SERUM ENZYMES AGAINST AIR POLLUTANTS EXPOSED ALBINO RATS.
Formulation and Evaluation of Buccal Drug Delivery System of Ketorolac Tromethamine Using Mucoadhesive Polymers
Signaling pathways associated with liver cancer stem cell therapy
PHARMACOLOGICAL ACTIVITIES OF ASTAXANTHIN
A review on ethnobotany, phytochemistry and pharmacology of Plantago major L. – nature's treasure
12
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
 

Article Detail

Label
Formulation, In-vitro Evaluation and Optimization of Nanoemulsion of Raloxifene Hydrochloride

Author: NARENDRA CHOTAI, BINAL R. PANDYA, RAJNIKANT M. SUTHAR, HARDIK K. PATEL
Abstract: The aim of the present work was to prepare nanoemulsion of raloxifene hydrochloride by high pressure homogenization method with a view to enhance its solubility and dissolution. The solubility of drug was determined in different oils, surfactants and co-surfactants. Pseudoternary phase diagrams were plotted on the basis of solubility data of drug in various components to evaluate the nanoemulsification region. The capmul MCM C8, tween 20 and propylene glycol were selected as the oil, surfactant and co-surfactant respectively for the formulation development. A box-behnken design was adopted for the preparation nanoemulsion possessing optimized characteristics. Concentration of oil (X1), concentration of Smix (X2), and homogenization pressure (X3) were selected as independent variables whereas globule size and cumulative % drug release after 24 hrs (Q24) were selected as dependent variables. Total fifteen batches (B1 to B15) were formulated and evaluated for different parameters such as globule size, polydispersibility index (PDI), drug content, % transmittance, refractive index (RI), pH, viscosity, in-vitro drug release study, zeta potential and transmission electron microscopy. Amongst all prepared batches B12 (oil-15%, Smix-50% and 35% water) showed satisfactory results of globule size and in-vitro drug release and it can be considered as optimized formulation. It was compared with marketed product and pure drug for their in-vitro release study and found to be promising formulation.
Keyword: Nanoemulsion, Phase diagram, Globule size, Zeta potential, Box-behnken design.
Download: Request For Article
 
INDEXED
Chemical Abstract Services
Scopus (Elsevier)
Embase(Elsevier)
Ulrich's International Periodical Dictionary
Indian Science Abstract
USER LOGIN
Username
Password
Login | Register
Forgot your password?
News & Events
Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477
Impact Factor for five years is 1.3 (2010 - 2014)